Table E1.
Self-reported symptom and disease characteristics reported by SARS-CoV-2 IgG+ and IgM+IgA−IgG− subjects
| Characteristic | Variable | IgG+ |
IgM+IgA−IgG− |
P value∗ | ||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| Any COVID-19 related symptoms between Feb 20 and June-21 | Yes | 196 | 89.5 | 35 | 68.6 | <.0001 |
| No | 23 | 10.5 | 16 | 31.4 | ||
| Disease symptoms experienced more than once between Feb 20 and June-21 | More than once | 64 | 32.7 | 14 | 40.0 | NS |
| Once | 132 | 67.3 | 21 | 60.0 | ||
| Total number of occasions with symptoms | 260 | 49 | NA | |||
| Bedbound during disease | Yes, ≥7 days | 23 | 8.8 | 1 | 2.1 | NS |
| Yes, 1-6 days | 114 | 43.8 | 21 | 43.8 | ||
| No | 123 | 47.3 | 26 | 54.2 | ||
| Hospitalization | Yes | 3 | 1.2 | 0 | 0.0 | NS |
| No | 257 | 98.8 | 48 | 100.0 | ||
| When were symptoms experienced? | Feb 20 | 12 | 4.7 | 1 | 2.1 | <.0001 |
| Mar 20 | 47 | 18.2 | 7 | 14.6 | ||
| Apr 20 | 31 | 12.0 | 6 | 12.5 | ||
| May 20 | 20 | 7.8 | 3 | 6.3 | ||
| Jun 20 | 13 | 5.0 | 3 | 6.3 | ||
| Jul 20 | 4 | 1.6 | 3 | 6.3 | ||
| Aug 20 | 4 | 1.6 | 3 | 6.3 | ||
| Sep 20 | 15 | 5.8 | 3 | 6.3 | ||
| Oct 20 | 20 | 7.8 | 10 | 20.8 | ||
| Nov 20 | 31 | 12.0 | 0 | 0.0 | ||
| Dec 20 | 22 | 8.5 | 1 | 2.1 | ||
| Jan-21 | 10 | 3.9 | 1 | 2.1 | ||
| Feb-21 | 7 | 2.7 | 0 | 0.0 | ||
| Mar-21 | 13 | 5.0 | 4 | 8.3 | ||
| Apr-21 | 6 | 2.3 | 3 | 6.3 | ||
| May-21 | 3 | 1.2 | 0 | 0.0 | ||
| Duration of symptoms | <1 week | 60 | 23.1 | 21 | 43.8 | NS |
| 1 week | 75 | 28.8 | 12 | 25.0 | ||
| 2 weeks | 73 | 28.1 | 10 | 20.8 | ||
| 3 weeks | 24 | 9.2 | 2 | 4.2 | ||
| ≥4 weeks | 28 | 10.8 | 3 | 6.3 | ||
NA, Not applicable.
∗
Chi-square test or Fisher exact test.